TITLE

RECAF BLOOD TEST DETECTS 92% OF CERVICAL CANCERS

PUB. DATE
June 2005
SOURCE
Worldwide Biotech;Jun2005, Vol. 17 Issue 6, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the completion of a study by BioCurex Inc. on the detection of cervical cancers with the use of the RECAF blood test, as of June 2005. Sensitivity of the traditional pap test in detecting high-grade lesions, according to the National Cancer Institute in the U.S.; Estimated market size for pap smears; Remarks of BioCurex CEO Ricardo Moro on the results of the study.
ACCESSION #
17147227

 

Related Articles

  • Ever Hear This From Your Gynecologist? Napoli, Maryann // HealthFacts;Aug2006, Vol. 31 Issue 8, p6 

    The article discusses a research on the role of regular screening with Pap tests for cervical cancer in delayed childbearing in the U.S. The National Cancer Institute explains how such tests may lead to additional diagnostic procedures that can produce precancerous lesions.

  • Pouzdanost CINtec p16INK4a citoloÅ¡kog imunohistohemijskog testa u skriningu prekanceroznih lezija grlića materice. Jović, Milena; Nenadić, Dane; Magić, Zvonko; Zoltarevski, Lidija; Đurđević-Vukomanović, Biserka; Tatomirović, Željka; Strelić, Nataša; Vojvodić, Danilo // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Mar2008, Vol. 65 Issue 3, p211 

    Background/Aim. Overexpression of p16INK4a has been found to be linked with genomic integration of high-risk human papillomavirus (HPV) and the developement of precancerous cervical intraepithelial lesions. The aim of this study was to examine is there a higher positive level of correlation...

  • BioCurex Updates Its Shareholders.  // Biotech Financial Reports;Jul2011, Vol. 18 Issue 7, p5 

    The article reports that chief executive officer (CEO) Ricardo Moro, of cancer diagnostics company BioCurex Inc., has sent a letter to update shareholders on the company's current and future programs. The letter provides information on programs including synthetic peptide for canine RECAF tests,...

  • NIH Releases Consensus Statement on Cervical Cancer.  // American Family Physician;11/15/1996, Vol. 54 Issue 7, p2310 

    Reports that the National Cancer Institute and the Office of Medical Applications of the National Institutes of Health (NIH) convened a consensus development conference regarding cervical cancer. Reason why NIH convened a conference; Key questions addressed by the participants as they weighed...

  • Visual Inspection: A Low-Tech Tool for Reducing Cervical Cancer Rates -- Johns Hopkins Expert Available to Discuss Results of Study.  // Ascribe Newswire: Medicine;10/2/2002, p18 

    This article reports on a study by researcher Paul D. Blumenthal and colleagues, published in the October 2, 2002 issue of the periodical "Journal of the National Cancer Institute," which shows that visual inspection of the cervix, or neck of the womb, coupled with immediate treatment of any...

  • Predictors of papanicolaou smear use among american samoan women. Mishra, Shiraz I.; Luce-Aoelua, Pat H.; Hubbell, F. Allan; Mishra, S I; Luce-Aoelua, P H; Hubbell, F A // JGIM: Journal of General Internal Medicine;May2001, Vol. 16 Issue 5, p320 

    To explore the rate and predictors of Papanicolaou (Pap) smear use among American Samoans, we conducted a survey of 986 randomly selected adult, self-identified Samoan women in American Samoa (n = 323), Hawaii (n = 325), and Los Angeles (n = 338). Only 46% of the women reported having a Pap...

  • The value of Pap tests.  // International Family Planning Perspectives;Dec96, Vol. 22 Issue 4, p139 

    Reports that between 1986 and 1991, 50,000 women were screened for cervical cancer in public health centers in Taipei, Taiwan, where the disease is the most common type of neoplasm among women. Amount of women who were diagnosed as having abnormal Pap smears; Percentage of married women in...

  • A Randomized Controlled Trial of Intervention to Promote Cervical Cancer Screening Among Chinese Women in North America. Taylor, Victoria M.; Hislop, T. Gregory; Jackson, J. Carey; Shin-Ping Tu; Yasui, Yutaka; Schwartz, Stephen M.; Chong Teh; Kuniyuki, Alan; Acorda, Elizabeth; Marchand, Ann; Thompson, Beti // JNCI: Journal of the National Cancer Institute;5/1/2002, Vol. 94 Issue 9, p670 

    Focuses on the randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. Response of women to follow-up survey; Presence of intervention effect in Vancouver than in Seattle; Improvement of Papanicolaou testing among Chinese women.

  • Cervical cancer consensus development.  // Public Health Reports;Mar/Apr96, Vol. 111 Issue 2, p102 

    Offers information on the National Cancer Institute and the National Institutes of Health Office of Medical Application Research's conference on the cancer of the cervix to be held on April 1 to 3, 1996.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics